Matches in Wikidata for { <http://www.wikidata.org/entity/Q89818568> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q89818568 description "article scientifique publié en 2020" @default.
- Q89818568 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89818568 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89818568 description "scientific article published on 17 February 2020" @default.
- Q89818568 description "wetenschappelijk artikel" @default.
- Q89818568 description "наукова стаття, опублікована 17 лютого 2020" @default.
- Q89818568 name "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 name "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 type Item @default.
- Q89818568 label "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 label "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 prefLabel "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 prefLabel "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 P1433 Q89818568-9A53C067-5309-41ED-B0C0-152C2AE2418A @default.
- Q89818568 P1476 Q89818568-9FD743E3-7CEF-4727-A471-19E0686D2868 @default.
- Q89818568 P2093 Q89818568-080612DA-D8CA-4E9D-A3D7-270C0A0C6972 @default.
- Q89818568 P2093 Q89818568-46CC94ED-5178-4E9D-969C-92750282B66F @default.
- Q89818568 P2093 Q89818568-7C1FCB50-7BD9-4BB3-B87B-99FF5370A5EC @default.
- Q89818568 P304 Q89818568-716771C1-7DC9-47E9-B47E-BDB6D1161DF2 @default.
- Q89818568 P31 Q89818568-5AAC19DB-4472-483B-AAF2-419864EF6CD2 @default.
- Q89818568 P356 Q89818568-B8FB2CCF-2BD9-4D20-8C99-3D3C507B9726 @default.
- Q89818568 P478 Q89818568-B208719D-82BD-4CBA-A777-E08D7A5FBAF3 @default.
- Q89818568 P50 Q89818568-72E02812-9034-4704-9F3E-09CCD2BB5817 @default.
- Q89818568 P577 Q89818568-B6CCF560-E116-4284-A4ED-8F80640A8DD0 @default.
- Q89818568 P698 Q89818568-8792AD45-5CF2-4B5B-B278-4AFA8A3F94E3 @default.
- Q89818568 P921 Q89818568-2E2A9A24-86D8-4C66-A8B4-0A48404C1D81 @default.
- Q89818568 P921 Q89818568-336A17FF-4278-4F04-BB5A-E5386C89BDF8 @default.
- Q89818568 P356 J.IJPHARM.2020.119159 @default.
- Q89818568 P698 32081798 @default.
- Q89818568 P1433 Q6051539 @default.
- Q89818568 P1476 "Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model" @default.
- Q89818568 P2093 "Amin Afkhami-Poostchi" @default.
- Q89818568 P2093 "Mansour Mashreghi" @default.
- Q89818568 P2093 "Mehrdad Iranshahi" @default.
- Q89818568 P304 "119159" @default.
- Q89818568 P31 Q13442814 @default.
- Q89818568 P356 "10.1016/J.IJPHARM.2020.119159" @default.
- Q89818568 P478 "579" @default.
- Q89818568 P50 Q88651589 @default.
- Q89818568 P577 "2020-02-17T00:00:00Z" @default.
- Q89818568 P698 "32081798" @default.
- Q89818568 P921 Q18554829 @default.
- Q89818568 P921 Q25419 @default.